|
|
Volumn 359, Issue 9316, 2002, Pages 1491-1492
|
|
FDA recommends bringing controversial IBS drug back.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALOSETRON;
CARBOLINE DERIVATIVE;
SEROTONIN ANTAGONIST;
ARTICLE;
DRUG APPROVAL;
FOOD AND DRUG ADMINISTRATION;
HEALTH CARE AND PUBLIC HEALTH;
HUMAN;
IRRITABLE COLON;
LEGAL APPROACH;
LEGAL ASPECT;
UNITED STATES;
HEALTH CARE AND PUBLIC HEALTH;
LEGAL APPROACH;
CARBOLINES;
COLONIC DISEASES, FUNCTIONAL;
DRUG APPROVAL;
HUMANS;
SEROTONIN ANTAGONISTS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 0037181885
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(02)08468-4 Document Type: Article |
|
Times cited : (6)
|
|
References (0)
|
